The Anatomic Pathology lab has experienced monumental changes in recent years expanding the pathologist's role beyond a cancer diagnosis to being a key contributor who delivers critical patient results defining treatment selection. The onslaught of genetic and molecular technologies and the increased availability of cancer targeted therapies has further added complexity to the pathologists' role as they learn new approaches to interpretation of results and reporting. In this era of personalized medicine, it is critical for pathologists to have access to tools supporting their expanded roles.
